193 related articles for article (PubMed ID: 23024296)
1. Fidaxomicin "chaser" regimen following vancomycin for patients with multiple Clostridium difficile recurrences.
Johnson S; Gerding DN
Clin Infect Dis; 2013 Jan; 56(2):309-10. PubMed ID: 23024296
[No Abstract] [Full Text] [Related]
2. Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.
Cornely OA; Miller MA; Fantin B; Mullane K; Kean Y; Gorbach S
J Clin Oncol; 2013 Jul; 31(19):2493-9. PubMed ID: 23715579
[TBL] [Abstract][Full Text] [Related]
3. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.
Cornely OA; Crook DW; Esposito R; Poirier A; Somero MS; Weiss K; Sears P; Gorbach S;
Lancet Infect Dis; 2012 Apr; 12(4):281-9. PubMed ID: 22321770
[TBL] [Abstract][Full Text] [Related]
4. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
Lancaster JW; Matthews SJ
Clin Ther; 2012 Jan; 34(1):1-13. PubMed ID: 22284993
[TBL] [Abstract][Full Text] [Related]
5. Fidaxomicin versus vancomycin for Clostridium difficile infection.
Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
[TBL] [Abstract][Full Text] [Related]
6. Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child.
Smeltzer S; Hassoun A
J Antimicrob Chemother; 2013 Jul; 68(7):1688-9. PubMed ID: 23463209
[No Abstract] [Full Text] [Related]
7. Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment of Clostridium difficile infections.
Poxton IR
Future Microbiol; 2010 Apr; 5(4):539-48. PubMed ID: 20353295
[TBL] [Abstract][Full Text] [Related]
8. Is fidaxomicin the drug of choice for treating Clostridium difficile-associated diarrhea in patients with cancer?
Green MR; Acharya UH; Yeager AM
J Clin Oncol; 2013 Dec; 31(34):4376-8. PubMed ID: 24166524
[No Abstract] [Full Text] [Related]
9. Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic.
Sears P; Ichikawa Y; Ruiz N; Gorbach S
Ann N Y Acad Sci; 2013 Jul; 1291():33-41. PubMed ID: 23672600
[TBL] [Abstract][Full Text] [Related]
10. Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.
Mullane KM; Cornely OA; Crook DW; Golan Y; Louie TJ; Miller MA; Josephson MA; Gorbach SL
Am J Nephrol; 2013; 38(1):1-11. PubMed ID: 23796582
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
12. Fidaxomicin (Dificid) for Clostridium difficile infection.
Med Lett Drugs Ther; 2011 Sep; 53(1373):73-4. PubMed ID: 21921871
[No Abstract] [Full Text] [Related]
13. [Dificid: fewer recurrences of clostridium difficile].
Perspect Infirm; 2013; 10(1):60. PubMed ID: 23379054
[No Abstract] [Full Text] [Related]
14. [Relapsing infections with Clostridium difficile].
Visser WE; Dingemans-Dumas AM; Bac DJ
Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
Brodszky V; Gulácsi L; Ludwig E; Prinz G; Banai J; Reményi P; Strbák B; Kertész A; Kopcsóné Németh I; Zsoldiné Urbán E; Baji P; Péntek M
Orv Hetil; 2013 Jun; 154(23):890-9. PubMed ID: 23728312
[TBL] [Abstract][Full Text] [Related]
17. Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
Saffouri G; Khanna S; Estes L; Pardi D
Am J Gastroenterol; 2014 Jun; 109(6):924-5. PubMed ID: 24896763
[No Abstract] [Full Text] [Related]
18. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
Cornely OA
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():28-35. PubMed ID: 23121552
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
Cornely OA; Nathwani D; Ivanescu C; Odufowora-Sita O; Retsa P; Odeyemi IA
J Antimicrob Chemother; 2014 Nov; 69(11):2892-900. PubMed ID: 25074856
[TBL] [Abstract][Full Text] [Related]
20. The changing face of Clostridium difficile: what treatment options remain?
Shen EP; Surawicz CM
Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
